MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2022 International Congress

    Improving timely administration of PD meds in the hospital by using “custom” schedules

    H. Azmi, F. Ruzicka, L. Cocoziello, J. Pederson, E. Clar, A. Rocco, F. Thomas (Oradell, USA)

    Objective: To determine if there are differences in timely administration of medications in hospitalized patients with Parkinson’s Disease (PD) when orders are placed for a…
  • 2022 International Congress

    Cognitive profiles at presentation and subsequent cognitive decline in PD-MCI.

    S. Mirza, S. Duff-Canning, M. Masellis, C. Marras (Toronto, Canada)

    Objective: To determine cognitive profiles in a Parkinson‘s Disease-Mild Cognitive Impairment (PD-MCI) cohort, and study the relationship between baseline cognitive phenotype and subsequent cognitive decline.…
  • 2022 International Congress

    Nigral microvasculature imaging in Parkinson’s disease

    S. Sharma, S. Buch, D. Reese, M. Haacke, M. Jog (London, Canada)

    Objective: The goal of this work is to image the microvasculature of the midbrain, in particular the substantia nigra in Parkinson’s disease (PD) patients using…
  • 2022 International Congress

    Pilot study of narrative medicine (NM) interventions in facilitating advance care planning (ACP) in Parkinson’s disease (PD): a feasibility study

    J. Jiao, B. Lobb, A. Hiller (Portland, USA)

    Objective: To demonstrate the feasibility of conducting NM interventions in PD and to describe NM’s potential impact upon ACP. Background: ACP is associated with increased…
  • 2022 International Congress

    IMPACT OF COVID 19 ON PARKINSON’S DISEASE: A CROSS SECTIONAL STUDY

    G. Desai, T. Nanayakkara, G. Pun, A. Chatterjee, N. Butt (READING, United Kingdom)

    Objective: To review the impact of Covid 19 on symptoms and signs of Parkinsons as well as general being in patients with Parkinson’s Disease at…
  • 2022 International Congress

    Phase-amplitude coupling between beta power and high frequency oscillations as a sensitive marker of parkinsonian state.

    M. Bočková, M. Lamoš, P. Daniel, M. Baláž, J. Chrastina, I. říha, I. Rektor (Brno, Czech Republic)

    Objective: The aim of this work was to study the potential clinical usefulness of the phase-amplitude coupling (PAC) between beta power and high frequency oscillations (HFO´s).…
  • 2022 International Congress

    Neuroanatomical underpinnings of apathy in Parkinson’s Disease

    C. Le Heron, E. Huey, N. Vanegas-Arroyave, Y. Gazes, S. Lee (New Zealand)

    Objective: To investigated the integrity of white matter tracts within basal ganglia-frontal networks in PD patients with and without apathy, and relate these to specific…
  • 2022 International Congress

    White Matter Correlates of Physical Therapy Measures in Parkinson’s disease Patients with Freezing of Gait

    V. Mishra, J. Longhurst, K. Sreenivasan, D. Cordes, A. Ritter, Z. Mari (Las Vegas, USA)

    Objective: To identify white-matter (WM) correlates of physical therapy (PT)-measures in Parkinson’s disease (PD) patients with freezing of gait (FOG). Background: Significant gap remains in…
  • 2022 International Congress

    Does aging influence eating behavior during COVID-19 pandemic in patients with Parkinson’s Disease in northeastern Mexico?

    C. López Botello, S. Castillo Torres, I. Estrada Bellmann, B. Chávez Luevanos (Monterrey, Mexico)

    Objective: The aim of the study was to examine nutritional behavioral age-related impact in Parkinson's Disease patients. Background: COVID-19 caused serious psychological and nutritional impact.…
  • 2022 International Congress

    The brain-age framework in Parkinson’s disease: evaluating MRI morphometry and sex-dimorphism

    G. Gonzalez-Escamilla, P. Farag, M. Bange, S. Groppa (Mainz, Germany)

    Objective: We aimed to develop an MRI brain-age prediction (BAP) model to evaluate differences between Parkinson’s disease (PD) and healthy controls (HC). We further evaluated…
  • « Previous Page
  • 1
  • …
  • 443
  • 444
  • 445
  • 446
  • 447
  • …
  • 553
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley